Form 4: Singular Genomics CFO Dalen Meeter Reports Stock Transactions

Chief Financial Officer of Singular Genomics Systems, Dalen Meeter, reports the vesting and settlement of restricted stock units (RSUs) into common stock.

Summary

• On March 15, 2024, Dalen Meeter, the Chief Financial Officer of Singular Genomics Systems, Inc. (OMIC), reported a transaction involving the vesting and settlement of restricted stock units (RSUs).
• 6,250 shares of common stock were issued to Meeter upon the settlement of vested RSUs.
• Each RSU represents a contingent right to receive one share of Singular Genomics' common stock.
• Following the transaction, Meeter directly owns 200,273 shares of common stock.
• Meeter also holds 75,000 Restricted Stock Units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about stock transactions.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency into the holdings of key personnel.

Stakeholder Impact

• The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
• The vesting of RSUs incentivizes the CFO to remain with the company and contribute to its success.

Key Dates